Review paper<br>Antiretroviral drugs usage in HIV-positive pregnant women

Maciej Osiński; Czesław Żaba

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2012
vol. 29

Send email

Copy url:

abstract:

Review paper
Antiretroviral drugs usage in HIV-positive pregnant women

Maciej Osiński

,

Czesław Żaba

Post Dermatol Alergol 2012; XXIX, 2: 132–135

Online publish date: 2012/04/24

View full text Get citation

In the last decade an enormous success in the prevention of mother-to-child transmission of HIV infection occurred globally, but there are still problems with availability of antiretroviral therapies (ART) in low-middle income countries. According to WHO guidelines, it is critical whether the pregnant woman is eligible for ART or not. Unfortunately, in most cases of HIV-positive pregnant women ART is started later than it is suggested in WHO guidelines. A risk of the mother-to-child infection with no ART amounts to around 19-36%. In the untreated group of infants, in 20% of cases, progression to AIDS occurs in the first year of life. Infection with HIV in infants is more difficult to diagnose and treat in comparison to adult HIV infection. Currently, use of the appropriate therapy allows to prevent mother-to-child infection in almost 100% of cases of HIV-positive pregnant women.

keywords:

Review paperAntiretroviral drugs usage in HIV-positive pregnant women

Maciej Osiński , Czesław Żaba

prophylaxis against vertical infection with HIV, HIV infection, antiretroviral drugs in pregnancy

Review paper
Antiretroviral drugs usage in HIV-positive pregnant women

Maciej Osiński

,

Czesław Żaba